Cargando…
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study
Despite anti-dsDNA antibodies constitute a wide range of specificities, they are considered as the hallmark for systemic lupus erythematosus (SLE). OBJECTIVE: To identify clinical phenotypes associated with anti-dsDNA antibodies, independently of any clinical diagnoses. METHODS: Patients with recent...
Autores principales: | Compagno, Michele, Rekvig, Ole P, Bengtsson, Anders A, Sturfelt, Gunnar, Heegaard, Niels H H, Jönsen, Andreas, Jacobsen, Rasmus Sleimann, Eilertsen, Gro Ø, Fenton, Christopher G, Truedsson, Lennart, Nossent, Johannes C, Jacobsen, Søren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225731/ https://www.ncbi.nlm.nih.gov/pubmed/25396058 http://dx.doi.org/10.1136/lupus-2013-000007 |
Ejemplares similares
-
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
por: Compagno, Michele, et al.
Publicado: (2016) -
The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
por: Rekvig, Ole Petter
Publicado: (2019) -
Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: does a gold standard dsDNA assay exist?
por: Trujillo Aguilera, Antonio, et al.
Publicado: (2023) -
Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility
por: Jönsen, Andreas, et al.
Publicado: (2004) -
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus
por: Nielsen, Christoffer T, et al.
Publicado: (2014)